GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Poxel POXEL.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.16

+2.76%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Poxel — daily POXEL

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Poxel on TradingView ↗
Market value
€8.4m
Last close × shares
Volume
273.8k
Shares, 9 Nov 2026

About Poxel

Its shares trade on Euronext Paris under the ticker POXEL.PA. It has been listed since 6 February 2015. In the fiscal year to 31 December 2024, it reported revenue of €6.6m and a net loss of €18.3m. At that date it held total assets of €14.9m and shareholders' equity of −€58.9m.

Poxel SA is a biopharmaceutical company, which engages in development of molecules for the potential treatment of type 2 diabetes. The company is headquartered in Lyon, Auvergne-Rhone-Alpes. The company went IPO on 2015-02-06. The firm develops drugs with a focus on Type 2 diabetes. The firm aims at developing drugs from preclinical to phase 2 clinical proof of concept. Its lead product, Imeglimin, is in clinical phase 2 study for Type 2 diabetes indication. A direct activator of AMPK for the treatment of Type 2 diabetes has started its preclinical development, and other projects in the research phase target diabetes and other metabolic diseases with small molecules that have a disease-modifying mechanism of action. Poxel SAS was spun out from Merck Serono. The firm cooperates with the Laboratory for Fundamental and Applied Bioenergetics, Sumitomo Dainippon Pharma, Joseph Fourier University and Department of Cell Physiology and Metabolism at the University of Geneva, Switzerland, among others.

Figures and description from our data supplier, not checked against the company's own report.

More about Poxel →

Latest on Poxel

Our reporting

We have not reported on Poxel yet.

Next results

24 Mar 2027

Due on 24 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Poxel's ticker?

Poxel trades as POXEL.PA on Euronext Paris, under ISIN FR0012432516.

What was Poxel's last closing price?

0.16 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Poxel next report results?

Results are expected on 24 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.